Clementia Pharmaceuticals (Clementia Pharmaceuticals) EV-to-EBITDA : -17.64 (As of Apr. 26, 2024)

Clementia Pharmaceuticals EV-to-EBITDA Chart

Clementia Pharmaceuticals Quarterly Data
	Dec14	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18
EV-to-EBITDA	Get a 7-Day Free Trial									-3.24	-3.08	-2.80	-2.10	-4.39

Competitive Comparison of Clementia Pharmaceuticals's EV-to-EBITDA

For the Biotechnology subindustry, Clementia Pharmaceuticals's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clementia Pharmaceuticals's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clementia Pharmaceuticals's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Clementia Pharmaceuticals's EV-to-EBITDA falls into.

Clementia Pharmaceuticals EV-to-EBITDA Calculation

Clementia Pharmaceuticals's EV-to-EBITDA for today is calculated as:

Clementia Pharmaceuticals's current Enterprise Value is $1,004.15 Mil.
Clementia Pharmaceuticals's EBITDA for the trailing twelve months (TTM) ended in Dec. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-56.91 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clementia Pharmaceuticals  (NAS:CMTA) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Clementia Pharmaceuticals's PE Ratio for today is calculated as:

Clementia Pharmaceuticals's share price for today is $26.35.
Clementia Pharmaceuticals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.780.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Clementia Pharmaceuticals EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Clementia Pharmaceuticals's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Clementia Pharmaceuticals (Clementia Pharmaceuticals) Business Description